Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Bioresour Technol ; 350: 126922, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35240277

ABSTRACT

Haslea ostrearia is a marine diatom known to produce and excrete the marenine blue pigment. Its controlled, continuous and intensified cultivation remains a challenge. Thus, a submerged membrane photobioreactor (MPBR) was implemented in order to simultaneously and continuously cultivate H. ostrearia and extract marennine. The MPBR was compared with a similar air-lift photobioreactor (without membrane), both working at a dilution rate equal to 0.1, 0.3 and 0.5 d-1. Contrary to the air-lift photobioreactor, the MPBR successfully operated at high dilution rate without biomass washout. The MPBR allowed continuously recovering marennine and reaching high cell density (555 ± 25 × 106 cells L-1 at D = 0.1 d-1), marennine concentration (36.00 ± 0.02 mg L-1 at D = 0.1 d-1) and marenine productivity (7.20 ± 0.01 mg L-1 d-1 at D = 0.5 d-1).


Subject(s)
Diatoms , Biomass , Phenols , Photobioreactors , Pigmentation
2.
Mar Drugs ; 19(2)2021 Jan 27.
Article in English | MEDLINE | ID: mdl-33513982

ABSTRACT

Exopolysaccharide (EPS) from marine microalgae are promising sources of a new generation of drugs. However, lot of them remain to be discovered and tested. In this study, EPS produced by Porphyridium marinum and its oligomers prepared by High Pressure Homogenizer have been tested for different biological activities, i.e., antibacterial, anti-fungal and antibiofilm activities on Candida albicans, as well as for their effects on the viability of murine breast cancer cells. Results have shown that all EPS samples present some biological activity. For antibacterial and antibiofilm activities, the native EPS exhibited a better efficiency with Minimum Inhibitory Concentration (MIC) from 62.5 µg/mL to 1000 µg/mL depending on the bacterial strain. For Candida albicans, the biofilm formation was reduced by about 90% by using only a 31.3 µg/mL concentration. Concerning breast cancer cells, lower molar masses fractions appeared to be more efficient, with a reduction of viability of up to 55%. Finally, analyses of polymers composition and viscosity measurements were conducted on all samples, in order to propose hypotheses involving the activities caused by the intrinsic properties of polymers.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Breast Neoplasms , Cell Survival/drug effects , Polysaccharides, Bacterial/pharmacology , Porphyridium , Animals , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/therapeutic use , Biofilms/growth & development , Breast Neoplasms/drug therapy , Cell Line, Tumor , Cell Survival/physiology , Dose-Response Relationship, Drug , Female , Mice , Microalgae/isolation & purification , Microbial Sensitivity Tests/methods , Polysaccharides, Bacterial/isolation & purification , Polysaccharides, Bacterial/therapeutic use , Porphyridium/isolation & purification
3.
Biotechnol Adv ; 37(1): 193-222, 2019.
Article in English | MEDLINE | ID: mdl-30500354

ABSTRACT

Research on marine microalgae has been abundantly published and patented these last years leading to the production and/or the characterization of some biomolecules such as pigments, proteins, enzymes, biofuels, polyunsaturated fatty acids, enzymes and hydrocolloids. This literature focusing on metabolic pathways, structural characterization of biomolecules, taxonomy, optimization of culture conditions, biorefinery and downstream process is often optimistic considering the valorization of these biocompounds. However, the accumulation of knowledge associated with the development of processes and technologies for biomass production and its treatment has sometimes led to success in the commercial arena. In the history of the microalgae market, red marine microalgae are well positioned particularly for applications in the field of high value pigment and hydrocolloid productions. This review aims to establish the state of the art of the diversity of red marine microalgae, the advances in characterization of their metabolites and the developments of bioprocesses to produce this biomass.


Subject(s)
Aquatic Organisms/genetics , Biofuels , Biotechnology/trends , Microalgae/genetics , Aquatic Organisms/chemistry , Biomass , Enzymes/chemistry , Enzymes/genetics , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/genetics , Metabolic Networks and Pathways/genetics , Microalgae/chemistry , Pigments, Biological/chemistry , Pigments, Biological/genetics
4.
Int J Biol Macromol ; 120(Pt B): 2106-2114, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30201560

ABSTRACT

The production of B-phycoerythrin (B-PE) from the red microalga Porphyridium marinum was optimized before to purify it and subsequently study its antioxidant activities. NaNO3, K2HPO4 and metal traces concentrations of the culture medium, and luminosity parameters were chosen, according to the Plackett-Burman design, as the most influent factors on the B-PE production by P. marinum. The optimization of these factors according to the Box-Behnken plan gave a maximum of B-PE production equal to 40 mg/g dry weight under the following conditions: NaNO3 = 3.4 g/L; K2HPO4 = 0 g/L; light intensity = 70 µmol photons/m2/s and metal solution = 1.5 mL/L. The B-PE also showed an interesting capacity to chelate Fe3+ (IC50 = 13.91 ±â€¯0.21 µg/mL) and a significant reducing power (OD700nm = 0.485 ±â€¯0.011 at 100 µg/mL). The present study reports the antioxidant potential of purified B-PE from P. marinum that could be potentially used as a source of bioactive protein for a wide range of cosmetic and pharmaceutical applications.


Subject(s)
Antioxidants/metabolism , Biotechnology/methods , Industry , Microalgae/metabolism , Phycoerythrin/biosynthesis , Porphyridium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...